{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:08:37Z","timestamp":1758416917239,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jns.2021.117363","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:10:24Z","timestamp":1614039024000},"page":"117363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Distinctive regional asymmetry in dopaminergic and serotoninergic dysfunction in degenerative Parkinsonisms"],"prefix":"10.1016","volume":"423","author":[{"given":"Ryuichi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Marumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Kashibayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jns.2021.117363_bb0005","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","article-title":"Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio","volume":"33","author":"Tossici-Bolt","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.jns.2021.117363_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3413\/Nukmed-0449-11-12","article-title":"123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques","volume":"51","author":"Kahraman","year":"2012","journal-title":"Nuklearmedizin"},{"issue":"2","key":"10.1016\/j.jns.2021.117363_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/bjp.bp.114.148643","article-title":"Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study","volume":"206","author":"Walker","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","article-title":"Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease","volume":"43","author":"Shimizu","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.jns.2021.117363_bb0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.mnm.0000202858.45522.df","article-title":"123I-FP-CIT in progressive supranuclear palsy and in Parkinson\u2019s disease: a SPECT semiquantitative study","volume":"27","author":"Filippi","year":"2006","journal-title":"Nucl. Med. Commun."},{"issue":"3","key":"10.1016\/j.jns.2021.117363_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [(123) I]-FP-CIT SPECT imaging: the [(123) I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2021.117363_bb0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/RLU.0b013e3182291a7b","article-title":"Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism","volume":"36","author":"Cuberas-Borros","year":"2011","journal-title":"Clin. Nucl. Med."},{"issue":"4","key":"10.1016\/j.jns.2021.117363_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.117363_bb0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O\u2019Brien","year":"2004","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.117363_bb0050","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2967\/jnumed.116.182139","article-title":"Analysis of extrastriatal (123)I-FP-CIT binding contributes to the differential diagnosis of Parkinsonian diseases","volume":"58","author":"Joling","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"Pt 7","key":"10.1016\/j.jns.2021.117363_bb0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/brain\/awh485","article-title":"Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson\u2019s disease","volume":"128","author":"Scherfler","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.117363_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.parkreldis.2020.07.008","article-title":"Extrastriatal (123)I-FP-CIT SPECT impairment in degenerative Parkinsonisms","volume":"78","author":"Nicastro","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.117363_bb0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nicl.2018.04.009","article-title":"Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies","volume":"19","author":"Joling","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.jns.2021.117363_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2017.04.026","article-title":"Usefulness of combining (123)I-FP-CIT-SPECT striatal asymmetry index and cardiac (123)I-metaiodobenzylguanidine scintigraphy examinations for diagnosis of Parkinsonisms","volume":"377","author":"Niimi","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2021.117363_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13139-013-0196-6","article-title":"Feasibility of PET template-based analysis on F-18 FP-CIT PET in patients with de novo Parkinson\u2019s disease","volume":"47","author":"Jeong","year":"2013","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0404.2011.01583.x","article-title":"[(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism","volume":"126","author":"Contrafatto","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2021.117363_bb0090","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.117363_bb0095","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"P.S.P.S.G. Movement Disorder Society-endorsed, Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.117363_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12194-018-0468-z","article-title":"Impact of quantitative index derived from 123I-FP-CIT-SPECT on reconstruction with correction methods evaluated using a 3D-striatum digital brain phantom","volume":"11","author":"Furuta","year":"2018","journal-title":"Radiol. Phys. Technol."},{"issue":"3","key":"10.1016\/j.jns.2021.117363_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120572","article-title":"The subcortical cocktail problem; mixed signals from the subthalamic nucleus and substantia nigra","volume":"10","author":"de Hollander","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jns.2021.117363_bb0110","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.117363_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2017.11.039","article-title":"Scan without evidence of dopaminergic deficit (SWEDD) in degenerative Parkinsonism and dementia with Lewy bodies: a prospective study","volume":"385","author":"Nicastro","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.117363_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.40","article-title":"Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder","volume":"2","author":"Cervenka","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2021.117363_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pain.2005.12.014","article-title":"Mesolimbic dopaminergic mechanisms and pain control","volume":"120","author":"Wood","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jns.2021.117363_bb0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1755-7682-3-24","article-title":"Dopaminergic reward system: a short integrative review","volume":"3","author":"Arias-Carrion","year":"2010","journal-title":"Int. Arch. Med."},{"issue":"11","key":"10.1016\/j.jns.2021.117363_bb0135","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/ene.13390","article-title":"Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson\u2019s disease","volume":"24","author":"Jaakkola","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.117363_bb0140","doi-asserted-by":"crossref","first-page":"101755","DOI":"10.1016\/j.nicl.2019.101755","article-title":"Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: an (123)I-FP-CIT SPECT study","volume":"22","author":"Joling","year":"2019","journal-title":"Neuroimage Clin."},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parkreldis.2012.07.008","article-title":"Long-duration Parkinson\u2019s disease: role of lateralization of motor features","volume":"19","author":"Munhoz","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.117363_bb0150","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1109\/JBHI.2016.2547901","article-title":"High-accuracy classification of Parkinson\u2019s disease through shape analysis and surface fitting in 123I-Ioflupane SPECT imaging","volume":"21","author":"Prashanth","year":"2017","journal-title":"IEEE J. Biomed. Health Inform."},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WAD.0b013e31824acd84","article-title":"An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia","volume":"27","author":"Song","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"9","key":"10.1016\/j.jns.2021.117363_bb0160","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s002590050295","article-title":"Differential distribution of striatal [123I]beta-CIT in Parkinson\u2019s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography","volume":"25","author":"Messa","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.jns.2021.117363_bb0165","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","article-title":"[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration","volume":"15","author":"Pirker","year":"2000","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jns.2021.117363_bb0170","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/mds.23179","article-title":"Midbrain SERT in degenerative Parkinsonisms: a 123I-FP-CIT SPECT study","volume":"25","author":"Roselli","year":"2010","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2021.117363_bb0175","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.63.8.1154","article-title":"Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis","volume":"63","author":"Seppi","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.117363_bb0180","first-page":"111","article-title":"Progressive supranuclear palsy: clinico-pathological and biochemical studies","volume":"16","author":"Jellinger","year":"1980","journal-title":"J. Neural Transm. Suppl."},{"issue":"2","key":"10.1016\/j.jns.2021.117363_bb0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3143\/geriatrics.28.226","article-title":"An autopsy case of progressive supranuclear palsy with central pontine myelinolysis","volume":"28","author":"Inagaki","year":"1991","journal-title":"Nihon Ronen Igakkai Zasshi"},{"issue":"4","key":"10.1016\/j.jns.2021.117363_bb0190","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1212\/WNL.46.4.931","article-title":"Autopsy-proven progressive supranuclear palsy in two siblings","volume":"46","author":"Tetrud","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1440-1789.2010.01134.x","article-title":"Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra","volume":"31","author":"Sakai","year":"2011","journal-title":"Neuropathology"},{"issue":"4","key":"10.1016\/j.jns.2021.117363_bb0200","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.25060","article-title":"(18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study","volume":"82","author":"Schonhaut","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00441-018-2832-z","article-title":"Lateralisation in Parkinson disease","volume":"373","author":"Riederer","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.jns.2021.117363_bb0210","doi-asserted-by":"crossref","first-page":"15761","DOI":"10.1038\/s41598-020-72321-y","article-title":"Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes","volume":"10","author":"Shigekiyo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2021.117363_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-020-05168-0","article-title":"A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis","author":"Iwabuchi","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:53:13Z","timestamp":1758383593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":43,"alternative-id":["S0022510X21000563"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117363","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctive regional asymmetry in dopaminergic and serotoninergic dysfunction in degenerative Parkinsonisms","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117363"}}